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Background. The interests in mesenchymal stem cells (MSCs) and their application in cell therapy have resulted in a better
understanding of the basic biology of these cells. Recently hypoxia has been indicated as crucial for complete chondrogenesis. We
aimed at analyzing bonemarrowMSCs (BM-MSCs) differentiation capacity under normoxic and severe hypoxic culture conditions.
Methods. MSCs were characterized by flow cytometry and differentiated towards adipocytes, osteoblasts, and chondrocytes under
normoxic or severe hypoxic conditions. The differentiations were confirmed comparing each treated point with a control point
made of cells grown in DMEM and fetal bovine serum (FBS). Results. BM-MSCs from the donors displayed only few phenotypical
differences in surface antigens expressions. Analyzing marker genes expression levels of the treated cells compared to their control
point for each lineage showed a good differentiation in normoxic conditions and the absence of this differentiation capacity in severe
hypoxic cultures. Conclusions. In our experimental conditions, severe hypoxia affects the in vitro differentiation potential of BM-
MSCs. Adipogenic, osteogenic, and chondrogenic differentiations are absent in severe hypoxic conditions. Our work underlines
that severe hypoxia slows cell differentiation by means of molecular mechanisms since a decrease in the expression of adipocyte-,
osteoblast-, and chondrocyte-specific genes was observed.
1. Introduction
Mesenchymal stemcells (MSCs) aremultipotent cells that can
be expanded ex vivo and induced, either in vitro or in vivo,
to terminally differentiate into multiple lineages [1–5]. These
cells are located in bone marrow (BM), around blood vessels,
in fat, skin, muscle, and other tissues, and their presence
contributes to the reparative capacity of these tissues. MSCs
from different tissue sources can have biologic distinctions.
In this way, MSCs derived from bone marrow show a higher
potential for osteogenic differentiation [6], while MSCs of
synovial origin show a greater tendency toward chondrogenic
differentiation [7]. Moreover, under identical culture con-
ditions of differentiation, MSCs isolated from the synovial
membrane show more chondrogenic potential than those
derived from bone marrow, periosteum, skeletal muscle, or
adipose tissue [8].
The recent use of autologous or allogenic stem cells has
been suggested as an alternative therapeutic approach for
treatment of cartilage defects [9], with these cells representing
a promising resource for different tissue engineering and
cell-based therapies [10]. The interests in MSCs and their
possible application in cell therapy have resulted in a better
understanding of the basic biology of these cells. Clinical
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trials for diseases such as osteogenesis imperfecta, graft-
versus-host disease, and myocardial infarction have shown
some promise, demonstrating the safe use of both allogeneic
and autologous cells [11–13]. In particular, in the last years,
researchers focused on the effect of oxygen tension on
MSCs and on differentiation. BM is one of the few organs
that is maintained in the body in a hypoxic state [14].
Hypoxia plays an important role during development and cell
differentiation [15]. The effect of hypoxic culture conditions
was analyzed and showed to improve MSCs yield and reduce
cells expansion time compared to the standard protocols
[16]. Hypoxic conditions promote chondrogenic differenti-
ation and enhance cartilage protein synthesis through the
upregulation of Sox9, type II collagen, and aggrecan [17, 18].
Concerning osteogenesis and adipogenesis, the studies are
controversial, probably due to different time exposures of
cells to hypoxia. Both an improvement [19] and a decrease
[20] of the differentiation capacity towards these lineages
have been reported.
In this study, we confirmed that the cells used in our
experiments were MSCs based on the combination of the
three minimal criteria proposed by the International Society
for Cellular Therapy in 2006 [21]. Furthermore, we analyzed
adipogenic, osteogenic, and chondrogenic differentiation
induced by commercial media both in normoxic and severe
hypoxic conditions. The differentiations were confirmed by
histologic, immunohistochemical and quantitative real-time
PCR techniques (qPCR).
2. Materials and Methods
2.1. Isolation and Culture of MSCs. The BM samples used to
isolate MSCs (BM-MSCs) were obtained from three patients
(mean age: 64 years, range: 55–82 years) who underwent total
hip replacement. The donors were not selected; the samples
submitted were processed as they arrived at the laboratory.
This study was approved by the institutional review board,
and informed consent was obtained from all subjects in the
study.
Isolated BM cells were cultured under standard cul-
ture condition (humidified atmosphere with 5% CO
2
), in
Dulbecco’s Modified Eagle’s Medium (DMEM), 20% fetal
bovine serum (FBS), and 1% penicillin and streptomycin
(P/S) (all from Sigma-Aldrich, St. Louis,MO,USA) until 90%
confluent. Preplating for 15 minutes in the first two passages
eliminated any fibroblasts remaining in the culture [22].
The cells were cultured and expanded until the beginning
of the differentiations experiments. At this point, when cells
reached 90% of confluence, they were trypsinized, washed,
and submitted both to phenotypical analysis and to differen-
tiation experiments.
2.2. Phenotypic Characterization Using Flow Cytometry. At
the third passage, after culture expansion, the cells were
trypsinized, washed, and analyzed by flow cytometry. Briefly,
the human BM-derived cells were harvested by trypsiniza-
tion, washed, and centrifuged at 300 g for 8 minutes. The
cells were counted prior to flow cytometry, and a total of
2×10
5 were transferred to fluorescence-activated cell sorting
(FACS) polypropylene tubes (NUNC, VWR International,
Denmark). The antibodies listed in Supplementary Table 1
were used for these experiments (See Supplementary Mate-
rial available online at http://dx.doi.org/10.1155/2013/232896).
Optimal amounts of monoclonal antibodies (mAbs) were
determined and added to each tube for 40 minutes at
4∘C in darkness. Most antibodies were conjugated with
fluorescein isothiocyanate (FITC) or phycoerythrin (PE)
and were characteristic for markers associated with mes-
enchymal and hematopoietic lineages. When necessary, cells
were incubated for 30 minutes at 4∘C in darkness with
a secondary FITC-conjugated antibody to allow binding
to the primary antibody. A control tube for each of the
chromogens used contained equivalent amounts of isotype
standards. A minimum of 25,000 cell events per assay were
acquired on a FACsCalibur flow cytometer (BD Biosciences,
Madrid, Spain). Datawere analyzed usingCellQuest Software
(BD Biosciences), and the results were expressed as positive
percentage.
2.3. Multipotential Characterization. At the time of flow
cytometry, the cells were differentiated towards three differ-
ent lineages (adipocyte, osteoblast, and chondrocyte). Differ-
entiation experiments were carried out both in normoxic and
severe hypoxic conditions.The term “normoxic conditions” is
used to indicate the standard culture condition correspond-
ing to humidified atmosphere with 21% O
2
. The term “severe
hypoxic conditions” is used to indicate the culture condition
corresponding to an atmosphere with 1% O
2
. The culture
conditions used to induce each differentiation are described
in the following paragraphs.
2.4. Adipogenic Differentiation. At the 3rd passage BM-
MSCs were detached using trypsin-EDTA (Sigma-Aldrich,
St. Louis, MO, USA), seeded at 1.5 × 105 cells/cm2 in a
chamber slide (BD Falcon, France), and cultured in growth
medium until confluence. Adipogenesis was induced by
culturing for three weeks in hMSC commercial adipogenic
differentiation medium (Lonza, Biowhittaker, Belgium), fol-
lowing the manufacturer’s instructions. Each differentiation
point was compared to a control point corresponding to cells
cultured for the same period of time inDMEMwith 20%FBS.
Differentiation was confirmed by staining techniques and
gene expression quantification using real time PCR (qPCR).
2.5. Osteogenic Differentiation. BM-MSCs at the 3rd pas-
sage were detached using trypsin-EDTA, seeded at 1.5 ×
10
5 cells/cm2 in a chamber slide, and cultured in growth
medium until confluence. Osteogenesis was induced by
culture for three weeks in hMSC Commercial Osteogenic
DifferentiationMedium (Lonza, Biowhittaker, Belgium).This
culture medium was changed every 3-4 days. Each differ-
entiation point was compared with a control point that
corresponded to cells cultured for the same period of time
with DMEM and 20% FBS. Differentiation was assessed
through histological and qPCR techniques.
2.6. Chondrogenic Differentiation. Chondrogenesis was
assessed using the micropellet formation (2.5 × 105 cells)
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Table 1: Sequences of qPCRprimers used for the amplification of humanmRNAcorresponding to adipogenic, osteogenic, and chondrogenic-
specific genes.
Gene name Forward primer (5󸀠-3󸀠) Reverse primer (5󸀠-3󸀠) mRNA ID number
Sox9 gtacccgcacttgcacaac tcgctctcgttcagaagtctc NM 000346
Col2A1 gtgtcagggccaggatgt tcccagtgtcacagacacagat NM 001844
Aggrecan (Agg) gcctacgaagcaggctatga gcacgccataggtcctga BC036445
Col1 gtgatgctggtcctgttggt caccatcgtgagccttctct NM 000088
FABP4 ggatgataaactggtggtgga cacagaatgttgtagagttcaatgc NM 001442
APM1 ggtgagaaaggagatccaggt tgctgagcggtatacataggc NM 004797
LPL agaacatcccattcactctgc ccatttgagcttcaacatgagt NM 000237
ALP gacggacccgtcactctc gtgcccgtggtcaattct NM 000478
OP cgcagacctgacatccagt ggctgtcccaatcagaagg NM 000582
TBP gcccatagtgatctttgcagt cgctggaactcgtctcacta NM 003194
technique [23], with some modifications. BM-derived cells
from the 3rd passage were detached using trypsin-EDTA
and centrifuged at 300 g for 10 minutes. The resulting
pellet was cultured in hMSC Commercial Chondrogenic
Differentiation Medium (Lonza, Biowhittaker, Belgium) for
2 weeks. The culture medium was changed every 3-4 days.
Each differentiation point was compared with cells cultured
for the same period of time with DMEM and 20% FBS. After
14 days, cell aggregates were embedded in Tissue-Tek OCT
compound (Sakura Finetek) and frozen. The presence of
hyaline cartilage-characteristic molecules, such as type II
collagen and proteoglycans, was detected by histological,
immunohistochemical, and qPCR techniques as described
below.
2.7. Histological Analyses. For adipogenesis evaluation, dif-
ferentiation was confirmed by detection of cytoplasmic lipid
droplets by oil red O staining after cell fixation in 4%
paraformaldehyde.
For osteogenesis evaluation, differentiation was analyzed
byAlizarin red staining after cell fixation in 4%paraformalde-
hyde, to assess the presence of calcium deposits.
For chondrogenesis evaluation, 4𝜇m-thick frozen sec-
tions of aggregates were stained with hematoxylin and eosin
(HE), Masson’s trichrome (MT), toluidine blue (TB), alcian
blue (AB), and safranin O (SaO) for proteoglycans and
collagens.
2.8. Immunohistochemical Analyses. For chondrogenesis
evaluation, 4𝜇m thick frozen sections were incubated with
primary antibodies to detect the presence of types I (Abcam,
Cambridge, UK) and II (Neomarker, Barcelona, Spain)
collagens, and with a polyclonal antibody to detect aggrecan
C-20 (Santa Cruz Biotechnology, Heidelberg, Germany)
(Supplementary Table 2). The peroxidase/DAB ChemMate
DAKO EnVision detection kit (Dako, Barcelona, Spain) was
used to determine antigen-antibody interactions. Negative
staining controls were achieved by omitting the primary
monoclonal antibody. Samples were visualized using an
optical microscope.
2.9. RNA Extraction. Isolation of total RNA from cell cul-
tures was accomplished using trizol reagent (Invitrogen,
Barcelona, Spain), following the manufacturer’s protocol.
RNA was assessed for quantity at 260 nm using a NanoDrop
spectrophotometer (Thermo Scientific, Madrid, Spain). The
A260/A280 ratio was calculated to assess quality and purity.
For each sample, 1 𝜇g of total RNA was further processed in
RT-PCR or stored at −80∘C until used.
2.10. cDNA Synthesis. Before reverse transcription, the total
RNA underwent DNase digestion (Fermentas, Spain) for
complete removal of DNA contamination. Subsequently, the
reverse transcription reaction was performed from 1 𝜇g of
total RNA using SuperScript First-Strand Synthesis System
for RT-PCR (Invitrogen, Spain), following themanufacturer’s
instructions. Briefly, 1𝜇g of total RNA, 0.5𝜇g oligo d(T),
0.5mM of dNTP mix, and 3 𝜇L of DEPC-treated water were
denatured at 65∘C for 5 minutes and chilled on ice for at
least 1 minute. Then, 2 𝜇L of 10x RT buffer, 5mM MgCl
2
,
0.01M DTT, and 40U of RNaseOUT Recombinant Ribonu-
clease Inhibitor were mixed, collected by centrifugation, and
incubated at 42∘C for 2 minutes. After incubation, 50U of
SuperScript RT was added and incubated at 42∘C for 50
minutes and 70∘C for 15 minutes in a Thermocycler (Gene
Amp PCR System 9700, Applied Biosystems, Spain). Finally,
samples were chilled on ice and incubated with 2U of RNAse
H for 20 minutes at 37∘C before proceeding to the next step.
Samples were stored at −20∘C before the amplification of
target cDNAs. Positive and negative controls were included
in each experiment. RNA extraction, reverse transcription-
PCR assay setup, and postreverse transcription-PCR product
analysis were carried out in separate dedicated rooms to
prevent crosscontamination.
2.11. Quantitative Real-Time Reverse Transcription-PCR Anal-
ysis (qRT-PCR). Real-time PCR analysis was performed
using the primers shown in Table 1 on a LightCycler 480
Instrument (Roche, Mannheim, Germany).
The PCR reaction consisted of 10 𝜇L of Master Mix 2x
concentrate, 0.25𝜇Mof each forward and reverse primer, the
cDNA template, and PCR-grade water up to a final volume of
20𝜇L in the LightCycler 480Multiwell Plate 96.Themultiwell
plate was loaded in the LightCycler 480 Instrument until the
PCR program started.
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The initial enzyme activation at 95∘C for 10 minutes was
followed by 50 cycles of target amplification consisting of
three sequential steps: 95∘C for 10 seconds (s), 61∘C for 5 s,
and 72∘C 7 s. After amplification, amelting curve analysis was
performed and a final cooling step was applied at 40∘C for
20 s.
The single amplification and expected size of each PCR
productwere verified.Theuse of 2% agarose gel electrophore-
sis, stained with SYBR Safe DNA gel stain (Invitrogen), of all
PCRproducts revealed a single band that corresponded to the
single-amplified products as predicted by the PCR melting
curve analysis.
PCR primers were positioned to span exon-intron
boundaries, reducing the risk of detecting genomicDNA.The
primers were purchased fromRoche (Mannheim, Germany).
The TATA box binding protein gene (TBP) was used as the
internal control housekeeping gene to normalize the amount
of target cDNA.
Data analysis was performed using LightCycler 480
Relative Quantification software (Roche). Relative levels of
expression were calculated by the 2−ΔΔCt method [24]. Each
assay was done at least in triplicate and included marker-
positive and marker-negative controls and reagent with no
template controls. Each data was normalized against the
housekeeping gene and compared with its corresponding
control point of cells grown in DMEM with 20% FBS. For
each gene expression, we assigned the value 1 to the lowest
level of expression, and the other values were measured as
relative expression levels (REL).
2.12. DNA Sequencing Analysis. At least one PCR product
coming from each real-time PCR experiment was used as
template DNA in order to verify the specificity of the ampli-
fied amplicon. PCR products were purified by an enzymatic
method (ExoSAP-IT, Amersham Biosciences, Spain). DNA
sequencing was performed on an ABI 3130XL (Applied
Biosystems, Spain) sequencer using BigDye Terminators
(Applied Biosystems, Spain). Forward and reverse specific
primers used were the same employed for the qPCR exper-
iments (Table 1).
2.13. Other Procedures. The procedures used to manipulate
the nucleic acids were those described inMolecular Cloning:
A Laboratory Manual by Sambrook et al. [25].
2.14. Statistical Analysis. Each experiment was repeated at
least three times.The statistical significance of the differences
between mean values was determined using a two-tailed
𝑡-test; 𝑃 < 0.05 was considered significant. Results are
expressed as the mean ± standard deviation (mean ± SD).
3. Results
3.1. Isolation of BM-MSCs Populations. Spindle-shaped bipo-
lar cells attached to the flask were observed at the first
medium change at 48 hours of culture. We expanded, dif-
ferentiated, and analyzed the surface antigens expression and
multipotentiality of the cells isolated from three donors.
3.2. Characterization of Culture Expanded BM-MSCs
3.2.1. Phenotypic Analysis. At the third passage, at the
beginning of the differentiation experiments, the cells
were characterized using flow cytometry. The antibodies
used were selected to characterize BM-MSCs population.
Briefly, we used CD34 and CD45, markers of hematopoietic
stem/progenitor cells; SSEA-4 and Stro-1, markers of embry-
onic stem cells; CD90, CD73, CD105, CD29, CD44, CD106,
and CD166, markers of mesenchymal stem/stromal cells.
Figure 1 shows surface marker expressions of one donor.
The cells from the three donors showed very similar expres-
sions of surface markers. Each antigen expression value was
expressed as positive percentage. In this way, CD73 andCD44
antigens were coexpressed at 94%. CD105 was expressed at
61% when alone and coexpressed with CD106 at 24%. On the
other hand, CD166 was expressed at 92%.The percentages of
CD90, CD29, and SSEA-4 expressions were 95%, 94%, and
83%, respectively. Cells from the three donors were negative
for Stro-1, CD45, and CD34 expressions.
3.2.2. Adipogenic Differentiation. After 21 days of culturewith
the appropriate differentiation medium or with 20% FBS
for the control points, the cells were stained with Oil Red
O for lipid droplets to evaluate adipogenic differentiation
(Figure 2(a)). All the controls resulted negative for staining,
showing the absence of lipid droplets. The cells grown in dif-
ferentiation medium in normoxic conditions were positively
stained, indicating differentiation, while the cells grown in
differentiationmedium in severe hypoxic conditionswere not
stained, indicating a marked decrease in differentiation.
To confirm these results, we extracted total RNA from
cells treated in the same way, retrotranscribed 1𝜇g of total
RNA, and analyzed it through qPCR (Figure 2(b)). We mea-
sured the expression levels of LPL, FABP4, and APM1marker
genes for adipogenic differentiation. In each experiment, each
gene expression level of cells treated with the differentiation
medium was compared to cells cultured in DMEMwith 20%
FBS (control points). In normoxic conditions, treated cells
showed higher levels of LPL, FABP4, and APM1 expressions
compared to the control points (972.13, 48934.74, and 1247.03
times, resp.) and were statistically significant (𝑃 < 0.005). In
severe hypoxic conditions, treatment of cells with differentia-
tion medium was not able to induce differentiation, and gene
expression levels of LPL, FABP4, and APM1 were 1.92, 0.14,
and 3.64 times the control points.These results confirmed the
histological stainings.
3.2.3. Osteogenic Differentiation. After 21 days of culture
with the differentiation medium or with 20% FBS for the
controls, the cells were stained with Alizarin Red for calcium
deposits (Figure 3(a)).The controlswere negative for staining.
The cells grown in differentiation medium in normoxic
conditions were positively stained, showing the presence of
calcium deposits and the presence of differentiation, while
the cells grown in differentiation medium in severe hypoxic
conditions were not stained, indicating a marked decrease in
differentiation.
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Figure 1: Phenotype of cells, at the third passage, isolated from human bone marrow of one donor. Antibodies listed in Supplementary Table
1 were used for this procedure. The figure shows representative histograms of multipotential mesenchymal stem cells obtained from FACS
analysis. Black line signifies the specific antibody; yellow line represents the isotype control.
To confirm these results, we extracted total RNA from
cells differentiated under the same conditions, retrotran-
scribed 1 𝜇g of total RNA, and analyzed it through qPCR
(Figure 3(b)). In each experiment, each gene expression
level of cells treated with the appropriate differentiation
medium was compared to cells cultured in DMEM with
20% FBS (control points). We measured the expression levels
of ALP and OP genes for osteogenic differentiation. The
three populations were capable of showing specific genes of
osteoblast differentiation. In normoxic conditions, ALP and
OP expression levels were, respectively, 19.14 times and 12.13
times higher than the control points, and the differences
were statistically significant (𝑃 < 0.05), while in severe
hypoxic conditions the expression levels of ALP andOPwere,
respectively, 1.73 and 1.13 times the controls.
3.2.4. Chondrogenic Differentiation. After 14 days of culture
with the differentiation medium or with 20% FBS for the
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(b)
Figure 2: Staining techniques of adipogenic differentiated cells and adipogenic-specific gene expression levels in normoxic and hypoxic
conditions. (a) Oil red O staining of the cells differentiated (DM) compared to their control point (CTL). The photos are relative to day 21 of
cultures in normoxic and hypoxic conditions. (b) We compared CTL and treated cells (Adip.). Expression levels of LPL, FABP4, and APM1
at day 21 of cultures in normoxic (∗∗𝑃 < 0.005) and hypoxic conditions.
controls, the aggregates were analyzed by histochemistry
using hematoxylin eosin (HE), Masson’s trichrome (MT),
toluidine blue (TB), alcian blue (AB), and Safranin O (SaO)
staining and immunohistochemistry for aggrecan and type I
and II collagens. These techniques confirmed chondrogenic
differentiation in normoxic conditions and the absence of
differentiation in severe hypoxic conditions. As shown in
Figure 4, the presence of collagens and proteoglycans could
be seen only in normoxic atmosphere. Immunohistochem-
istry results for aggrecan (Agg) and Col1 were negative (data
not shown).
To confirm these results, we extracted total RNA from
cells differentiated under the same conditions, retrotran-
scribed 1 𝜇g of total RNA, and analyzed it through qPCR
(Figure 5). We measured the expression levels of Sox9, Agg,
Col1A1, and Col2A1 marker genes for chondrogenic differen-
tiation. In each experiment, each gene expression level of cells
treatedwith the differentiationmediumwas compared to that
of cells cultured in DMEMwith 20% FBS (control points). In
normoxic conditions (Figure 5), treated cells showed higher
levels of Sox9, Agg, and Col1A1 expressions compared to
the control points (6.87, 25.58, and 17.47 times, resp.) and
were statistically significant (𝑃 < 0.005). In severe hypoxic
conditions (Figure 5), the expression of Sox9, Agg andCol1A1
genes were 0.65, 3.31, and 5.36 times the control points.
The Col2A1 gene was detected only in the treated cells in
normoxic conditions with a Cp value of 31 (media of the three
donors). Also these results confirmed the staining.
4. Discussion
Stem cells represent an attractive source for tissue engineer-
ing and reparative medicine [13]. Very little is known regard-
ing the mechanisms that regulate stemness, self-renewal, and
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Figure 3: Staining techniques of osteogenic differentiated cells and osteogenic-specific gene expression levels in normoxic and hypoxic
conditions. (a) Alizarin red staining of the cells differentiated (DM) compared to their control point (CTL). The photos are relative to day 21
of cultures in normoxic and hypoxic conditions. (b) We compared controls points (CTL) and treated cells (Osteo.). Expression levels of ALP
and OP at day 21 of cultures in normoxic (∗𝑃 < 0.05) and hypoxic conditions.
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Figure 4: Histochemical (HE: hematoxylin-eosin; TB: toluidine blue; AB: alcian blue; MT: Masson’s trichrome; SaO: safranin O) and
immunohistochemical results for collagen type 2 (Col2A1) cells differentiated toward chondrocytes. The photos are relative to day 14 of
cultures in chondrogenic differentiation medium in normoxic conditions (up) and in hypoxic conditions (down).
maturation ofMSCs.The importance of tissue environmental
factors, such as oxygen tension, in the induction of MSC dif-
ferentiation has been previously studied [26–28]. Moreover,
the studies from Simon and Keith [29] revealed that oxygen
is a regulator of the stem cell biology.
Conventional in vitro cell cultures are often carried
out under ambient oxygen concentration corresponding to
21% (defined as “normoxic”). However, physiologic oxygen
pressure is lower and varies from tissue to tissue between 1%
and 13% [30]. Therefore the 21% oxygen tension used as the
normoxic condition exceeds the partial pressure of oxygen
in most mammalian tissues, indicating that oxygen concen-
tration during standard in vitro culture of primary human
cells is often not adapted to the in vivo situation [31]. Marrow
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Figure 5:Chondrogenic-specific gene expression levels in normoxic
and hypoxic conditions. In these figures we compared control points
(CTL) and treated cells (CM). Expression levels of Sox9, Agg, and
Col1A1 at day 14 of cultures in normoxic conditions (∗∗𝑃 < 0.005)
and in hypoxic conditions (∗𝑃 < 0.05).
stem cells are generally cultured in the presence of 21% O
2
,
but the pO
2
in the bone marrow is much lower, between 1%
and 7% [32]. This suggests for bone marrow-derived cells the
use of hypoxic in vitro conditions resembling their natural
physiological environment. Mathematical models of the pO
2
distribution in human bonemarrow suggest a gradient across
themarrow from the relatively well-oxygenated sinuses to the
rather hypoxic endosteal region [33]. It is well known that
high pO
2
could be toxic, causing oxidative stress, due to the
generation of reactive oxygen species (ROS) that can damage
DNA, proteins, and lipids [34]. Therefore excess electrons
are transferred to oxygen leading to the harmful oxidation
of adjacent molecules [35]. For this reason hypoxia may
decrease the intracellular ROS production and accumulation
leading to an increase in the metabolic efficiency [34]. In this
way, cultivation of MSCs under hypoxic conditions mimics
the naturalmicroenvironment of these cells and represents an
important prerequisite to study cell proliferation, differentia-
tion, senescence, metabolic balance, and other physiological
processes [34]. Moreover, the fact of studying BM-MSCs
differentiation in the presence of low oxygen concentration
may be relevant to understanding the lack of repair processes
that occur with severe hypoxia such as in situations of
severe vascular ischemia, which occurs in patients with
atherosclerosis or diabetes and in patients with inflammatory
conditions such as arthritis.
Attending the low O
2
tension of BM in vivo, we studied
the capacity of BM-MSCs to differentiate toward adipocyte,
osteoblast, and chondrocyte comparing severe hypoxic and
normoxic conditions. To drive their differentiation, we
treated cells isolated from three different donors with com-
mercial medium. In all the experiments performed, in nor-
moxic conditions cells from the three donors were able to dif-
ferentiate toward adipogenic, chondrogenic, and osteogenic
lineages. However, when the differentiation treatments were
carried out under severe hypoxic conditions, the same cells
from the same donors were not able to differentiate. Severe
hypoxic environment inhibited completely the three-lineage
differentiation potential of our BM-MSCs. The absence of
differentiation capacity under hypoxia was seen both with
histological and immunohistochemical analyses. In addition,
qPCR analysis of themarker genes for each lineage confirmed
these results. We saw an upregulation of the genes analyzed
when the differentiations were carried out under normoxia
and a loss of this induction under severe hypoxia.The way by
which severe hypoxia slows cell differentiation is by means
of molecular mechanisms; indeed we have seen a decrease in
the expression of adipocyte-, osteoblast-, and chondrocyte-
specific genes. Moreover, our MSCs were isolated from
osteoarthritic (OA) patients. Therefore, this inhibition of cell
differentiation may explain the lack of repair processes that
occur with severe hypoxia in patients with inflammatory
conditions such as osteoarthritis. Moreover, it is possible that
MSCs from OA donors show different in vitro differentiation
potentials than those isolated from normal donors. In this
way, not only the influence of different oxygen tensions but
also the origin of the isolated BM-MSCs may influence the in
vitro differentiation capacity.
In the last years, several papers have focused on the
effects of hypoxia on stem cells isolated from different tissues
and different species [36–38]. The effects of low oxygen
concentration on cell growth have also been examined by
several authors in different cell models such as rat marrow-
derived mesenchymal stem cells and murine fibroblast,
respectively [39, 40]. In this regard, D’Ippolito et al. [41]
demonstrated that low oxygen concentration (1, 3, 5, and
10% O
2
) increases cell proliferation, obtaining the maximal
difference in cells maintained at 3% O
2
. Moreover, low
pO
2
inhibits osteoblastic differentiation, suggesting that low
oxygen tension (pO
2
) seems to be a cell culture condition
that is critical to maintain MSCs in a less differentiated state.
They showed that lineage-specific differentiation of stem cells
may be enhanced when these cells are exposed to higher pO
2
,
indicating that oxygen concentration regulates the balance
between self-renewal and differentiation of MSCs. In other
works, Holzwarth et al. [31] assessed that reduced oxygen
tension (1 to 3% O
2
) severely impaired adipogenic and
osteogenic differentiations of human MSCs. Also, Malladi et
al. [42] demonstrated that osteogenesis and chondrogenesis
of adipose-derived mesenchymal cells were inhibited in vitro
by hypoxic culture conditions (2% O
2
). All these data are
in agreement with the “niche” model proposed by Schofield
[43], where stemcells ormore developmentally primitive cells
in the BM are located within a specific area characterized by
a unique microenvironment, low in pO
2
, that contributes to
maintaining a limitless potential of stem cells to self-renew,
that is, proliferate without differentiation. The same positive
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effect of low pO
2
on maintaining stemness has also been
shown in other stem cell types [44, 45].
In contrast, other groups reported positive effects of
reduced oxygen tensions on MSCs plasticity [20, 46]. For
example, Lennon et al. [39] reported that rat marrow stro-
mal cells showed increased extracellular mineralization in
cultures maintained at low pO
2
compared to normoxic
conditions. Also, in several in vitro studies, low oxygen
concentrations have been found to stimulate differentiation
processes, inducing the cells toward the osteogenic, adi-
pogenic, or chondrogenic lineage [47, 48]. In this regard,
Wang et al. [49] reported that adipose-derived mesenchymal
cells cultured in 5% O
2
and suspended in alginate beads
showed a decrease in growth and an increase in chondrogenic
differentiation. Moreover, Robins et al. [27] have shown
that low pO
2
can promote chondrocytic differentiation from
mesenchymal stem cells. These contradictory data can be
explained by the variety of species involved, the type of
culture design (which would change the type of oxygen
gradients to which the cells were exposed), differences of
culture conditions (such as growth factor supplementation of
the media), the method of differentiation applied, the pO
2
chosen, and the time points studied. In this way, Grayson
et al. [19] reported an increase in adipogenic and osteogenic
differentiations in long-term 3D cultures of bone marrow-
derived mesenchymal stem cells under hypoxia. Compared
to our work and our results, in Grayson’s experiments [19]
cells isolated from bone marrow were both expanded and
differentiated in 3D architecture under hypoxic conditions. In
our work we applied severe hypoxic conditions only during
the differentiation experiments, and the 3D culture system
was only applied during chondrogenic differentiations.
As known from the literature, severalmolecular pathways
involved in cellular metabolism are altered under hypoxia
[50]. MSCs are characterized by metabolic flexibility and
are able to survive hypoxic conditions [34, 51]. Hypoxia
stabilized hypoxia-inducible factor-1 𝛼 (HIF-1𝛼). HIF-1𝛼 is
a transcriptional factor that activates more than 40 genes
and plays essential roles in a variety of cellular and systemic
homeostatic responses to hypoxia [50]. This transcriptional
factor downregulates mitochondrial oxygen consumption
[52] and upregulates key markers of stem cells like Oct-4,
Rex-1, and SSEA4 [41]. We hypothesized that the relationship
between HIF-1𝛼, cells proliferation, and stem cell markers
could explicate our results and the absence of differentiation
under severe hypoxic conditions. In addition, several papers
support this hypothesis [16, 53, 54]. In this regard, Carrancio
et al. [16] reported that hypoxic culture conditions compared
to the standard protocols showed to improve MSCs yield
and reduce cells expansion time. Also, Ohnishi et al. [54]
analyzed the gene expression of rat BM-MSCs in hypoxia and
observed an upregulation of genes involved in development,
cell proliferation, and cell survival. Finally, Dos Santos et al.
[53] reported that hypoxia promotes cell proliferation and
expansion. During proliferation, the majority of the cells
undergo cell division and cannot begin the cellular mech-
anisms involved in differentiation processes. Therefore the
use of low pO
2
levels to increase the in vitro survival or
self-renewal of human mesenchymal stem cells represents an
important improvement in stem cell research that could be
crucial for obtaining a high number of cells for therapeutic
purposes.
In conclusion, we have shown that severe hypoxic condi-
tions are able to abolish the differentiation capacity of BM-
MSCs when applied during in vitro directed differentiation.
Our work underlines that severe hypoxia slows cell differenti-
ation by means of molecular mechanisms since a decrease in
the expression of adipocyte-, osteoblast-, and chondrocyte-
specific genes was observed.
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